If you have any questions, please email our support team at [email protected] or call us toll-free at 1-888-862-1210.
Diabetes, antidiabetic medications and risk of depressiona population-based cohort and nested case-control study
According to the results of the RCT for patients with monogenic obesity ( LEPR or POMC deficiency) and acquired hypothalamic obesity, setmelanotide can reduce body weight and inhibit appetite to a certain extent, and common adverse reactions include injection site reactions, skin hyperpigmentation, nausea, diarrhea, and abdominal pain, with occasional occurrences of sexual adverse reactions, depression, and suicidal ideation [51,52]
discuss sourcing preferences with your provider
Always consult with a healthcare professional for personalized guidance
We have therefore included a table of all our statistical analyses with effect sizes as a reference for power analyses for future studies